EDITORIAL REVIEW REQUIRED — EXPRESS DRAFT. This is an unpublished draft. Some claims may be unconfirmed. Check dates, sources, claims, photographs, and video rights before publishing.
Health authorities in the British Virgin Islands are cracking down on the underground market for unregulated weight-loss injections, which have been proliferating through informal online channels. According to BVI News, Chief Medical Officer Dr Ronald Georges issued the warning after reports surfaced that sellers were distributing these products via closed WhatsApp groups and Facebook pages, with some residents also importing them through courier services for personal use or resale.
The Ministry of Health and Social Development emphasized that legitimate weight-management medicines exist but must be prescribed and monitored by registered medical practitioners. Products obtained outside official channels carry significant risks: they may contain unknown or harmful ingredients, arrive in incorrect doses, or be stored improperly—all factors that increase the likelihood of serious adverse effects.
The ministry outlined a sobering list of potential complications, ranging from severe nausea and vomiting to dehydration, allergic reactions, pancreatitis, and liver or kidney damage. In some cases, patients have required hospital treatment. The health department advised anyone who has already obtained these injections to stop using them and consult a medical professional or pharmacist before proceeding.
Residents experiencing severe abdominal pain, persistent vomiting, fainting, breathing difficulties, facial swelling, fever, or signs of infection following an injection should seek immediate medical attention. The ministry also warned that those selling, distributing, or administering unregulated injectable products through unlawful channels face potential investigation and enforcement action.
To help authorities combat the illegal trade, the BVI is encouraging residents to report suspected unlawful sales or distribution to Gracia Wheatley-Smith, Chief of Drugs and Pharmaceuticals, at (284) 468-9850 or via email. Reports should include product photographs, advertisement screenshots, seller details, and purchase or delivery information where available.
Weight-loss injections, including GLP-1 receptor agonists such as semaglutide, have gained popularity globally in recent years for weight management. However, the proliferation of unregulated versions—often sourced from overseas suppliers and marketed through social media—has created a public health concern in many jurisdictions, including the Caribbean.
This warning is directly relevant to Caribbean residents and diaspora communities, as the informal online marketplace for weight-loss products operates across borders and social media platforms widely used throughout the region. The BVI’s enforcement action reflects broader Caribbean health challenges around access to legitimate pharmaceuticals and the appeal of unregulated alternatives.
Sources and attribution
CVCA Express Draft: verification pending; WordPress publication is manual.